Hepatitis C virus - related cryoglobulinemic vasculitis with renal involvement current possibilities of diagnostic and treatment
- Authors: Milovanova S.Y.1, Kozlovskaya(Lysenko) L.V1, Milovanova L.Y.1, Gordovskaya N.B1, Ignatova T.M1, Taranova M.V1, Androsova T.V1
-
Affiliations:
- Sechenov First Moscow State Medical University (Sechenov University)
- Issue: Vol 91, No 6 (2019)
- Pages: 124-130
- Section: Articles
- URL: https://journals.rcsi.science/0040-3660/article/view/59012
- DOI: https://doi.org/10.26442/00403660.2019.06.000254
- ID: 59012
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
S. Yu Milovanova
Sechenov First Moscow State Medical University (Sechenov University)д.м.н., в.н.с. НИО здоровьесберегающих технологий Научно-технологического парка биомедицины; тел: +7(903)143-50-50; e-mail: sveta@milovanova.ru; ORCID: 0000-0002-2687-6161 Moscow, Russia
L. V Kozlovskaya(Lysenko)
Sechenov First Moscow State Medical University (Sechenov University)д.м.н., проф. каф. внутренних, профессиональных болезней и ревматологии медико-профилактического факультета; ORCID: 0000-0002-1166-7308 Moscow, Russia
L. Yu Milovanova
Sechenov First Moscow State Medical University (Sechenov University)д.м.н., проф. каф. внутренних, профессиональных болезней и ревматологии медико-профилактического факультета; ORCID: 0000-0002-5599-0350 Moscow, Russia
N. B Gordovskaya
Sechenov First Moscow State Medical University (Sechenov University)к.м.н., доц. каф. внутренних, профессиональных болезней и ревматологии медико-профилактического факультета Moscow, Russia
T. M Ignatova
Sechenov First Moscow State Medical University (Sechenov University)д.м.н., в.н.с. НИО здоровьесберегающих технологий Научно-технологического парка биомедицины Moscow, Russia
M. V Taranova
Sechenov First Moscow State Medical University (Sechenov University)к.м.н., доц. каф. внутренних, профессиональных болезней и ревматологии медико-профилактического факультета; ORCID: 0000-0002-7363-6195 Moscow, Russia
T. V Androsova
Sechenov First Moscow State Medical University (Sechenov University)к.м.н., доц. каф. внутренних, профессиональных болезней и ревматологии медико-профилактического факультета Moscow, Russia
References
- Gorevic P.D, Kassab H.J, Levo Y, et al. Mixed cryoglobulinemia: Clinical aspects and long - term follow - up of 40 patients. Am J Med. 1980;69:287-308. PMID: 6996482
- Meltzer M, Franklin E.C, Elisa K, et al. Cryoglobulinemia - a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med. 1966;40:837-56. PMID: 4956871
- Brouet J.C, Clouvel J.P, Danon F, et al. Biologic and clinical significance of cryoglobulins. Am J Med. 1974;57:775-88. PMID: 4216269
- Agnello V, Romain P.L. Mixed cryoglobulinemia secondary to hepatitis C virus infection. Reum Dis Clin North Am. 1996;22(1):1-21. PMID: 8907062
- Ferri C, Mascia M.T. Cryoglobulinemic vasculitis: Review. Curr Opin Rheumatol. 2006;18:54-63. PMID: 4216269
- D’Amico G. Renal involvement in hepatitis С infection: Cryoglobulinemic glomerulonephritis. Kidney Int. 1998;54:650-87. PMID: 9690235
- Charles E.D, Dustin L.B. Hepatitis C virus induced cryoglobulinemia. Kidney Int. 2009;76(8):818-24. doi: 10.1038/ki.2009.247
- Ferri C. Mixed cryoglobulinemia. Orphanet J Rare. 2008;3:25. doi: 10.1186/1750-1172-3-25
- Тэгай С.В., Лопаткина Т.Н., Косминкова Е.Н., Козловская Л.В. Поражение почек, ассоциированное с вирусами гепатитов В и С. Consilium Med. 2002;4(7):337-41.
- Saadoun D, Landau D.A, Calabrese L.H, Cacoub P. Hepatitis C-associated mixed cryoglobulinemia: a crossroad between autoimmunity and lymphoproliferation. Rheumatology. 2007;46:1234-42. doi: 10.1093/rheumatology/kem132
- Милованова С.Ю., Игнатова Т.М., Козловская Л.В. Особенности течения хронического гепатита С с криоглобулинемией. Клиническая гепатология. 2006;2(1):15-8.
- Cacoub P, Poynard T, Ghillani P, et al. Extrahepatic manifestations of chronic hepatitis c. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum. 1999;42:2204-12. doi: 10.1002/1529-0131
- Mc Guire B.M, Julian B.A, Bynon J.S, et al. Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med. 2006;144:735-41. PMID: 16702589
- Arase Y, Ikeda K, Murashima N, et al. Glomerulonephritis in autopsy cases with hepatitis C virus infection. Intern Med. 1998;37:836-40. doi: 10.2169/internalmedicine.37.836
- Jonson R.J, Gretch D.R, Couser W.G, et al. Hepatitis C virus - associated glomerulonephritis. Effect of α-interferon therapy. Kidney Int. 1994;46:1700-4. PMID: 7535369
- Trejo O, Ramos-Casals M, Garcia-Carrasco M. Cryoglobulinemia: study of etiologic factors and clinical and immunologic in 443 patients fr om a simple center. Medicine. 2001;8:252-62. PMID: 11470986
- Cacoub P, Delluc A, Saadoun D, et al. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vaskulitis: wh ere do we stand? Ann Rheum Dis. 2008;67(3):283-7. doi: 10.1136/ard.2006.065565
- Ferri C, Sebastiani M, Antonelli A, et al. Current treatment of hepatitis C-associated rheumatic diseases. Arthritis Res Ther. 2012;14:215-21. doi: 10.1186/ar3865
- Милованова С.Ю., Лысенко (Козловская) Л.В., Милованова Л.Ю., Мрыхин Н.Н., Русских А.В. HCV-ассоциированная смешанная криоглобулинемия и В-клеточная неходжкинская лимфома - патогенетически связанные проблемы. Терапевтический архив. 2018;(6):112-21. doi: 10.26442/terarkh2018906112-120
- Игнатова Т.М., Козловская Л.В., Гордовская Н.Б., Чернова О.А., Милованова С.Ю., Новиков П.И., Некрасова Т.П., Бекетова Т.В., Мухин Н.А. Криоглобулинемический васкулит, ассоциированный с вирусом гепатита С: 20-летний опыт лечения. Терапевтический архив. 2017;89(5):46-52. doi: 10.17116/terarkh201789546-52
- Emery J.S, Kuczynsky M, La D, et al. Efficacy and safety of direct acting antiviral for the treatment of mixed cryoglobulinemia. Am J Gastroenterol. 2017;112:1298-308. doi: 10.1038/ajg.2017.49
- Saadoun D, Pol S, Ferfar Y, et al. Efficacy and safety of sofosbuvir plus daclatasvir for treatment of HCV-associated cryoglobulinemia vasculitis. Gastroenterol Hepatol. 2017;15:575-83. doi: 10.1053/j.gastro.2017.03.006
- Gragnani L, Piluso A, Urraro T, et al. Virological and clinical response to interferon - free regimens in patients with HCV-related mixed cryoglobulinemia:preliminary results of a prospective pilot study. Curr Drug Targets. 2017;18:772-85. doi: 10.2174/1389450117666160208145432
- Jean-Michel Pawlotsky, Alessio Aghemo, Geoffrey Dusheiko, Xavier Forns, Massimo Puoti, Christophe Sarrazin. EASL Recommendations on Treatment of Hepatitis C 2018. European Association for the Study of the Liver (EASL). doi: 10.1016/j.jhep.2018.03.026
- Executive summary of the 2018 KDIGO hepatitis C in CKD Guideline: welcoming advances in evaluation and management. Kidney Int. 2018;94:663-73. doi: 10.1016/j.kisu.2018.06.001
- Saxena V, Koraishy F.M, Sise M.E, et al. Safety and efficacy of sofosbuvir - containing regimens in hepatitis C-infected patients with impaired renal function. Liver Int. 2016;36:807-16. doi: 10.1111/liv.13102
- Nazario H.E, Ndungu M, Modi A.A. Sofosbuvir and simeprevir in hepatitis C genotype 1 - patients with end - stage renal disease on haemodialysis or GFR<30 ml/min. Liver Int. 2016;36:798-801. doi: 10.1111/liv.13025
- Li T, Qu Y, Guo Y, Wang L. Efficacy and safety of direct acting antiviral therapies for hepatitis C virus patients with stage 4-5 chronic kidney disease: A meta - analysis. Liver Int. 2016;37:974-81. doi: 10.1111/liv.13336
- Comarmond C, Garrido M, Pol S, et al. Direct - acting antiviral therapy restores immune tolerance to patients with hepatitis C virus - induced cryoglobulinemia vasculitis. Gastroenterology. 2017;152:2052-62. doi: 10.1053/j.gastro.2017;02.037
- Sise M.E, Bloom A.K, Wisocky J, Chung R.T. Treatment of Hepatitis C Virus-Associated Mixed Cryoglobulinemia with Sofosbuvir-Based Direct-Acting Antiviral Agents. Hepatology. 2015;63:408-17. doi: 10.1002/hep.28297
- Rutlenge S.M, Chung R.T, Sise M.E. Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis. Hemodialysis Int. 2018;22:81-96. doi: 10.1111/hdi.12649
- Cornella S.L, Stine J.G, Kelly V, Caldwell S.H, Shah N.L. Persistence of mixed cryoglobulinemia despitecure of hepatitis C with new oral antiviral therapyincluding direct - acting antiviral sofosbuvir: A caseseries. Postgrad Med. 2015;127:413-7.
- Saadoun D, Thibault V, Ahmed S.N.S, et al. Sofosbuvir plus ribavirin for hepatitis C virus - associated cryoglo - bulinaemia vasculitis: VASCUVALDIC study. Ann Rheum Dis. 2015;75:1777-82.
- Cacoub P, Ahmed S.A, Ferfar Y, Pol S, et al. long - term efficacy of interferon - tree antiviral treatment regimens in patients with hepatitis C virus - associated cryoglobulinemia vasculitis. Clin Gastroenterol Hepatol. 2019;17:518-26. doi: 10.1016/j.cgh.2018.05.021
- Landau D, Saadoun D, Halfon P, et al. Relapse of hepatitis C virus - associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. Arthritis Rheum. 2008;58(2):604-11. doi: 10.1002/art.23305
- Giannini C, Petrarca A, Monti M, et al. Associated between persistent lymphatic infection by hepatitis C virus after antiviral treatment and mixed cryoglobulinemia. Blood. 2008;111:2943-5. doi: 10.1182/blood-2007-09-112490